OP-2507
OP-2507 is a prostacyclin analog. OP-2507 can increase brain glucose levels in mice, suppress the breakdown of energy metabolism under hypoxic conditions, and has a protective effect against changes in cyclic nucleotides in hypoxic brain tissue (specifically, an increase in cyclic AMP and a decrease in cyclic GMP) . OP-2507 provides protective effects against brain hypoxia and edema[1].
Product Specifications
CAS Number
101758-79-6
UNSPSC
12352005
Target
Others
Type
Reference compound
Related Pathways
Others
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/op-2507.html
Smiles
O=C(OC)CCCCC1=N[C@]2([H])[C@]([C@@H](/C=C/[C@@H](O)[C@H]3CC[C@@H](CCC)CC3)[C@H](O)C2)([H])C1
Molecular Formula
C25H41NO4
Molecular Weight
419.60
References & Citations
[1]Masuda Y, et al. Protective effect of a new prostacyclin analogue OP-2507 against cerebral anoxia and edema in experimental animals. Eur J Pharmacol. 1986 Apr 29;123 (3) :335-44.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
KN210171LP 1 Kit
Calcitonin receptor (CALCR) Human Gene Knockout Kit (CRISPR)
Sign In for Pricing
View Details 
TRC-B569661-25MG 25 mg
1-Bromo-4-(3-bromophenoxy)benzene-2,3,5,6-d4
Sign In for Pricing
View Details